MustGrow Biologics Statistics
Total Valuation
MGROF has a market cap or net worth of 29.51 million. The enterprise value is 27.53 million.
| Market Cap | 29.51M |
| Enterprise Value | 27.53M |
Important Dates
The next estimated earnings date is Thursday, April 23, 2026.
| Earnings Date | Apr 23, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 62.85M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +2.48% |
| Shares Change (QoQ) | +4.95% |
| Owned by Insiders (%) | 10.87% |
| Owned by Institutions (%) | n/a |
| Float | 54.94M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.45 |
| PB Ratio | 14.13 |
| P/TBV Ratio | 15.10 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -6.02 |
| EV / Sales | 4.98 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -8.03 |
Financial Position
The company has a current ratio of 1.89, with a Debt / Equity ratio of 0.20.
| Current Ratio | 1.89 |
| Quick Ratio | 1.15 |
| Debt / Equity | 0.20 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.12 |
| Interest Coverage | -17.99 |
Financial Efficiency
Return on equity (ROE) is -202.96% and return on invested capital (ROIC) is -92.74%.
| Return on Equity (ROE) | -202.96% |
| Return on Assets (ROA) | -65.98% |
| Return on Invested Capital (ROIC) | -92.74% |
| Return on Capital Employed (ROCE) | -178.94% |
| Weighted Average Cost of Capital (WACC) | 8.42% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 1.45 |
| Inventory Turnover | 5.63 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -47.99% in the last 52 weeks. The beta is 0.67, so MGROF's price volatility has been lower than the market average.
| Beta (5Y) | 0.67 |
| 52-Week Price Change | -47.99% |
| 50-Day Moving Average | 0.47 |
| 200-Day Moving Average | 0.74 |
| Relative Strength Index (RSI) | 46.24 |
| Average Volume (20 Days) | 5,169 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MGROF had revenue of 5.41 million and -4.57 million in losses. Loss per share was -0.09.
| Revenue | 5.41M |
| Gross Profit | 669,780 |
| Operating Income | -3.93M |
| Pretax Income | -4.57M |
| Net Income | -4.57M |
| EBITDA | n/a |
| EBIT | -3.93M |
| Loss Per Share | -0.09 |
Balance Sheet
The company has 2.36 million in cash and 419,076 in debt, with a net cash position of 1.94 million.
| Cash & Cash Equivalents | 2.36M |
| Total Debt | 419,076 |
| Net Cash | 1.94M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 2.09M |
| Book Value Per Share | 0.04 |
| Working Capital | 1.92M |
Cash Flow
In the last 12 months, operating cash flow was -3.42 million and capital expenditures -7,765, giving a free cash flow of -3.43 million.
| Operating Cash Flow | -3.42M |
| Capital Expenditures | -7,765 |
| Free Cash Flow | -3.43M |
| FCF Per Share | n/a |
Margins
Gross margin is 12.37%, with operating and profit margins of -72.64% and -84.52%.
| Gross Margin | 12.37% |
| Operating Margin | -72.64% |
| Pretax Margin | -84.52% |
| Profit Margin | -84.52% |
| EBITDA Margin | n/a |
| EBIT Margin | -72.64% |
| FCF Margin | n/a |
Dividends & Yields
MGROF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.48% |
| Shareholder Yield | -2.48% |
| Earnings Yield | -15.50% |
| FCF Yield | -11.62% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MGROF has an Altman Z-Score of 2.7 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.7 |
| Piotroski F-Score | 3 |